journal article·2024-09-18Open access

Application of the Self-Assembling Peptide Hydrogel RADA16 for Hemostasis during Tonsillectomy: A Feasibility Study

Joshua Michaels, Anna I. Kaleva, Laura Bateman, Oliver Wakelam, Joanna Stephens

Abstract

Tonsillectomy is a common surgical procedure but carries a high risk of readmission for secondary bleeding and pain. This study evaluated the feasibility and effectiveness of using the hemostatic self-assembling peptide hydrogel RADA16 (PuraBond, 3-D Matrix SAS; Caluire et Cuire, France) to control bleeding from the tonsillectomy wound bed. Readmission/re-operation rates were compared between a prospective case series of 21 primarily adult tonsillectomy patients treated with topical RADA16 and an untreated historical Control group of 164 patients who underwent tonsillectomy by 10 surgeons at a single tertiary hospital in the UK between March 2019 and June 2022. Cumulative readmission rates for any reason were 2-fold elevated in Control subjects (18.9%; n = 31/164 subjects) compared to patients treated intra-operatively with RADA16 hemostatic hydrogel (9.5%; n = 2/21) (p = 0.378). Readmission rates for postoperative bleeding were 3-fold higher in Controls (14.6%; n = 24/164 subjects) than in the RADA16-treated group (4.8%; n = 1/21) (p = 0.317). A similar rate of retreatment for pain was recorded in the Control (4.3%; n = 7/164) and RADA16 (4.8%; n = 1/21) groups (p = 0.999). Two Control subjects (1.2%) required re-operation for recalcitrant bleeding; no RADA16 subject (0.0%) required re-operation for any reason. No device-related adverse events occurred in the RADA16 group. Surgeons were pleased with the easy learning curve and technical feasibility associated with intra-operatively administering RADA16 hemostatic hydrogel. Intra-operative hemostasis using RADA16 peptide hydrogel was straightforward and was associated with a trend of 3-fold lower rates of readmission for postoperative bleeding events than untreated Control subjects.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Hemostasis and retained surgical items · Electrospun Nanofibers in Biomedical Applications · Oral and gingival health research

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Otolaryngology, North West Anglia NHS Foundation Trust, Peterborough PE3 9GZ, UK

Department of Otolaryngology, Cambridge University Hospitals NHS Foundation Trust, Cambridge CB2 0QQ, UK

Royal Hospitals Bath NHS Foundation Trust, Bath BA1 3NG, UK

Norfolk and Norwich University Hospitals NHS Foundation Trust, Norfolk NR4 7UY, UK

East and North Hertfordshire NHS Trust, Stevenage SG1 4AB, UK

Funding

3-D Matrix Ltd. (Tokyo, Japan)

References (27)

Show source-provided references
1. Ear, M.A. (2024, August 26). Nose & Throat Surgery: GIRFT Programme National Specialty Report, National Health Services UK. Available online: https://gettingitrightfirsttime.co.uk/wp-content/uploads/2019/12/ENT-Report-Nov19-M.pdf.
2. Hemostasis in Tonsillectomy10.1016/j.otc.2016.03.008 ↗
3. Conservative management versus tonsillectomy in adults with recurrent acute tonsillitis in the UK (NATTINA): A multicentre, open-label, randomised controlled trial10.1016/S0140-6736(23)00519-6 ↗
4. Sankar, S., O’Neill, K., Bagot D’Arc, M., Rebeca, F., Buffier, M., Aleksi, E., Fan, M., Matsuda, N., Gil, E.S., and Spirio, L. (2021). Clinical Use of the Self-Assembling Peptide RADA16: A Review of Current and Future Trends in Biomedicine. Front. Bioeng. Biotechnol., 9.10.3389/fbioe.2021.679525 ↗
5. Discovery and design of self-assembling peptides10.1098/rsfs.2017.0028 ↗
6. Self-assembling peptide RADA16: A promising scaffold for tissue engineering and regenerative medicine10.2217/nnm-2023-0161 ↗
7. US Food and Drug Administration (2024, August 26). 510(k) Premarket Notification K210098, Summary. “Hemostatic Device for Endoscopic Gastrointestinal Use”; PuraStat®; 3-D Matrix Inc., Available online: https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm?ID=K210098.
8. 3-D Matrix Europe SAS (2021, August 26). PuraStat® Absorbable Haemostatic Material Instructions for Use. Available online: https://www.nicolai-medizintechnik.de/anweisungen/544_IFU_PuraStat_03_2014.pdf.
9. US Food and Drug Administration (2024, August 26). 510(k) Premarket Notification K183015, Summary. “Polymer, Ear, Nose and Throat, Synthetic, Absorbable”; PuraSinus®; 3-D Matrix Inc., Available online: https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm?ID=K183015.
10. A novel self-assembling peptide for hemostasis during endoscopic submucosal dissection: A randomized controlled trial
11. A novel fully synthetic and self-assembled peptide solution for endoscopic submucosal dissection-induced ulcer in the stomach10.1016/j.gie.2015.11.015 ↗
12. A novel haemostatic agent based on self-assembling peptides in the setting of nasal endoscopic surgery, a case series10.1016/j.ijscr.2017.11.024 ↗
13. RADA16, a Self-Assembling Peptide (Sap) for Haemostasis in Nasal Endoscopic Surgery, a Case Series in Australia
14. Evaluating the role of the self-assembling topical haemostat PuraBond® in transoral robotic surgery (tors) for oropharyngeal cancer: A case series10.1016/j.amsu.2022.104302 ↗
15. Topical hemostatic agents in surgery: Review and prospects
16. UK National Health Service, Health Research Authority (2024, July 17). Postmarket Surveillance Studies Exempt from Research Ethics Committee Approval and Oversight. Available online: https://www.hra-decisiontools.org.uk/ethics/glossary.html#P.
17. Anatomy and physiology of the palatine tonsils, adenoids, and lingual tonsils10.1016/j.wjorl.2021.04.003 ↗
18. The Royal College of Surgeons of England (2024, July 15). National Prospective Tonsillectomy Audit: Final Report of an Audit Carried out in England and Northern Ireland between July 2003 and September 2004. Available online: https://www.rcseng.ac.uk/-/media/files/rcs/library-and-publications/non-journal-publications/national-prospective-tonsillectomy-audit-final-report-2005.pdf.
19. The surgical arrest of post-tonsillectomy haemorrhage: Hospital Episode Statistics 12 years on10.1308/rcsann.2018.0034 ↗
20. PROSPECT guideline for tonsillectomy: Systematic review and procedure-specific postoperative pain management recommendations10.1111/anae.15299 ↗
21. In situ tissue engineering with synthetic self-assembling peptide nanofiber scaffolds, PuraMatrix, for mucosal regeneration in the rat middle-ear10.2147/IJN.S47279 ↗
22. Oumrani, S., Barret, M., Bordaçahar, B., Beuvon, F., Hochart, G., Pagnon-Minot, A., Coriat, R., Batteux, F., and Prat, F. (2019). Application of a self-assembling peptide matrix prevents esophageal stricture after circumferential endoscopic submucosal dissection in a pig model. PLoS ONE, 14.10.1371/journal.pone.0212362 ↗
23. Topical biomaterials to prevent post-tonsillectomy hemorrhage10.1186/s40463-019-0368-1 ↗
24. Wound healing: A cellular perspective10.1152/physrev.00067.2017 ↗
25. Biomaterials and Advanced Technologies for Hemostatic Management of Bleeding10.1002/adma.201700859 ↗
26. Engineered Hemostatic Biomaterials for Sealing Wounds10.1021/acs.chemrev.1c01015 ↗
27. A transparent synthetic peptide hydrogel as a haemostatic agent in athermal nerve sparing robot-assisted radical prostatectomy: An observational study10.21037/tau-23-403 ↗